KEITH A BAGGERLY to Biomarkers
This is a "connection" page, showing publications KEITH A BAGGERLY has written about Biomarkers.
Connection Strength
0.024
-
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clin Cancer Res. 2015 Jun 15; 21(12):2704-14.
Score: 0.014
-
Statistical contributions to proteomic research. Methods Mol Biol. 2010; 641:143-66.
Score: 0.010